Unicentric Castleman Disease Presenting As a Retroperitoneal Peripancreatic Mass: A Report of Two Cases and Review of Literature

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2018 Sep 20

PMID 30228787

Citations 10

Authors

Jia-Lin Cheng

Jing Cui

Yi Wang

Zong-Zhen Xu

Feng Liu

Shu-Bin Liang

Hu Tian

Affiliations

Soon will be listed here.

Abstract

Castleman disease (CD) is a rare disorder of lymph nodes and related tissues. CD generally occurs in the mediastinum, as well as in cervical, retroperitoneal and axillary regions. The disease is classified into two major types: unicentric CD (UCD) and multicentric CD. The occurrence of UCD in the retroperitoneal peripancreatic region is quite rare. We encountered two cases of retroperitoneal peripancreatic UCD in our hospital during the past three years. Following a series of medical examinations, including magnetic resonance imaging, computed tomography, ultrasonography and postoperative histopathological examination, these two patients were diagnosed with UCD, which presented as a retroperitoneal peripancreatic mass. The mass in each patient was completely excised, and no postoperative radiochemotherapy was administered. Both patients recovered well without recurrence during a follow-up period of 30 mo and 8 mo.

Citing Articles

Castleman disease mimicking accessory spleen on imaging: A case report.

Ayoobi Yazdi N, MomeniAmjadi A, Kermanipour R, Alizadeh S, Salahshour F, Tahamtan M Radiol Case Rep. 2024; 20(1):651-656.

PMID: 39583236 PMC: 11585472. DOI: 10.1016/j.radcr.2024.09.143.

Clinical features and outcomes of retroperitoneal unicentric Castleman disease resected as sarcomas: insights from a high-volume sarcoma center.

Gao H, Li W, Zou B, Liu S, Miao C Front Surg. 2024; 11:1371968.

PMID: 39301171 PMC: 11410775. DOI: 10.3389/fsurg.2024.1371968.

Unicentric Castleman Disease: A Rare Diagnosis of Radiological and Histological Correlation.

Maqbool S, Javed A, Idrees T, Anwar S Indian J Otolaryngol Head Neck Surg. 2022; 75(2):975-978.

PMID: 36373120 PMC: 9638322. DOI: 10.1007/s12070-022-03253-4.

Retroperitoneal Unicentric Castleman's disease, a case report.

Yazdi S, Nazar E Ann Med Surg (Lond). 2022; 79:104109.

PMID: 35860095 PMC: 9289496. DOI: 10.1016/j.amsu.2022.104109.

Unicentric Castleman disease: multidetector computed tomography classification with surgical and pathologic correlation.

Sun X, Du Y, Zhang Y, Wang R, Hou D Quant Imaging Med Surg. 2021; 11(8):3562-3568.

PMID: 34341731 PMC: 8245968. DOI: 10.21037/qims-20-1033.

References

Charalabopoulos A, Misiakos E, Foukas P, Tsapralis D, Charalampopoulos A, Liakakos T . Localized peripancreatic plasma cell Castleman disease. Am J Surg. 2010; 199(5):e51-3. DOI: 10.1016/j.amjsurg.2009.05.020. View

Dalla Pria A, Pinato D, Roe J, Naresh K, Nelson M, Bower M . Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients. Blood. 2017; 129(15):2143-2147. DOI: 10.1182/blood-2016-10-747477. View

Musters A, Assaf A, Gerlag D, Tak P, Tas S . Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's Disease. Front Immunol. 2015; 6:625. PMC: 4676110. DOI: 10.3389/fimmu.2015.00625. View

Dong A, Dong H, Zuo C . Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT. Clin Nucl Med. 2013; 39(1):e69-72. DOI: 10.1097/RLU.0b013e31827a25fd. View

Siegel M, Ghafouri S, Ajmera R, Simon G . Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease. Int J Infect Dis. 2016; 48:49-51. DOI: 10.1016/j.ijid.2016.05.005. View

Shah D, Darji P, Lodha S, Bolla S . Unicentric Castleman's disease of abdomen. J Radiol Case Rep. 2013; 7(3):26-33. PMC: 3661424. DOI: 10.3941/jrcr.v7i3.1031. View

Munshi N, Mehra M, van de Velde H, Desai A, Potluri R, Vermeulen J . Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma. 2014; 56(5):1252-60. DOI: 10.3109/10428194.2014.953145. View

Talarico F, Negri L, Iusco D, Corazza G . Unicentric Castleman's disease in peripancreatic tissue: case report and review of the literature. G Chir. 2008; 29(4):141-4. View

Holzle F, Landers A, Platz-Baudin C, Basrei D, Wolff K . [Castleman's disease]. Mund Kiefer Gesichtschir. 2005; 9(2):121-5. DOI: 10.1007/s10006-004-0592-2. View

10.

Stevens E, Strowd R, Mott R, Oaks T, Wilson J . Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman's disease. Spine J. 2009; 9(9):e18-22. DOI: 10.1016/j.spinee.2009.04.011. View

11.

Chan K, Lade S, Prince H, Harrison S . Update and new approaches in the treatment of Castleman disease. J Blood Med. 2016; 7:145-58. PMC: 4976903. DOI: 10.2147/JBM.S60514. View

12.

Talat N, Belgaumkar A, Schulte K . Surgery in Castleman's disease: a systematic review of 404 published cases. Ann Surg. 2012; 255(4):677-84. DOI: 10.1097/SLA.0b013e318249dcdc. View

13.

Jain P, Milgrom S, Patel K, Nastoupil L, Fayad L, Wang M . Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol. 2017; 178(3):403-412. PMC: 5903684. DOI: 10.1111/bjh.14672. View

14.

Castleman B, IVERSON L, MENENDEZ V . Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956; 9(4):822-30. DOI: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4. View

15.

Jain P, Prieto V, Manning J, Fowler N, Medeiros L, Kanagal-Shamanna R . Synchronous presentation of intra-nodal follicular dendritic cell sarcoma and Castleman disease. Am J Hematol. 2016; 92(5):478-479. DOI: 10.1002/ajh.24603. View

16.

Schaefer I, Gunnel H, Schweyer S, Korenkov M . Unicentric castleman's disease located in the lower extremity: a case report. BMC Cancer. 2011; 11:352. PMC: 3171385. DOI: 10.1186/1471-2407-11-352. View

17.

Wang H, Pittaluga S, Jaffe E . Multicentric Castleman disease: Where are we now?. Semin Diagn Pathol. 2016; 33(5):294-306. PMC: 5003700. DOI: 10.1053/j.semdp.2016.05.006. View

18.

Baek H, Kook H, Han D, Shin M, Kim H, Hwang T . Unicentric Castleman disease relapsed after rituximab-CHOP chemotherapy or radiation therapy in an adolescent. J Pediatr Hematol Oncol. 2012; 34(5):e206-8. DOI: 10.1097/MPH.0b013e3182352dc7. View

19.

Ghosh A, Pradhan S, Talwar O . Castleman's disease - hyaline vascular type - clinical, cytological and histological features with review of literature. Indian J Pathol Microbiol. 2010; 53(2):244-7. DOI: 10.4103/0377-4929.64335. View

20.

Xu J, Zhou B, Cao H, Wang B, Yan S, Zheng S . Surgical management of isolated retroperitoneal Castleman's disease: A case report. Oncol Lett. 2016; 11(3):2123-2126. PMC: 4774416. DOI: 10.3892/ol.2016.4177. View